Fractionation experiments in head and neck cancer: The lessons so far

Clinical Oncology

Volumn 9, Issue 5, 1997, Pages 302-307

  Morgan, D A L ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; CLONOGENESIS; DOSE CALCULATION; DOSE RESPONSE; HEAD CANCER; HUMAN; HYPOXIC CELL; LONG TERM CARE; NECK CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSENSITIVITY; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; TIME; TISSUE REACTION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030720303     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80063-9     Document Type: Review

References (28)

1. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
2. Hansen O, Overgaard J, Hansen HS, et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumour differentiation. Radiother Oncol 1997;43:47-51.
3. Board of the Faculty of Clinical Oncology, the Royal College of Radiologists. Guidelines for the management of unscheduled interruption or prolongation of a radical course of radiotherapy. London: Royal College of Radiologists, 1996.
4. 3 laryngeal cancer using radiotherapy. Radiother Oncol 1992;24:215-20.
5. Saunders MI, Dische S. Radiotherapy employing three fractions per day over a continuous period of twelve days. Br J Radiol 1986;59:523-5.
6. Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys 1980;7:99-104.
7. Bäckström A, Jackobsson PA, Littbrand B, et al. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta Radiol Ther Phys Biol 1973;12:401-6.
8. Svoboda VHJ. Radiotherapy by several sessions a day. Br J Radiol 1974;48:131-3.
9. Van den Bogaert W, van der Schueren E, Horiot JC, et al. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC. Int J Radiat Oncol Biol Phys 1982;8:1649-55.
10. Nguyen TD, Demange L, Froissait D, et al. Rapid hyperfractionated radiotherapy: clinical results in 178 advanced squamous cell carcinomas of the head and neck. Cancer 1985;56:16-19.
11. Morgan DAL, Bradley PJ, MacLennan KA. Early results of radiotherapy for advanced laryngeal cancer using three small fractions per day. Acta Oncol 1987;26:437-40.
12. Gray AJ. Treatment of advanced head and neck cancer with accelerated fractionation. Int J Radiat Oncol Biol Phys 1986;12:9-12.
13. Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985;55:2100-4.
14. Million RR, Parsons JT and Cassisi NJ. Twice-a-day irradiation technique for squamous cell carcinomas of the head and neck. Cancer 1985;55:2096-9.
15. Details about the trial RTOG 9003 can be found at the following URL site: http://www.rtog.org/summaries/
16. Ang KK, Peters LJ. Concomitant boost radiotherapy in the treatment of head and neck cancers. Semin Radia Oncol 1992;2:31-3.
17. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy. Radiother Oncol 1992; 25:231-41.
18. Horiot JC, Bontemps P, Begg AC, et al. Radiothérapie hyperfractionnée et accelérée dans les cancers de la tete et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique. Bull Cancer Radiothér 1996;83:314-20.
19. Overgaard J, Sand Hansen H, Sapru W, et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - preliminary report from the DAHANCA 6 and 7 trial [abstract]. Radiother Oncol 1996;40(Suppl 1):S31.
20. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report on acute toxicity. Radiother Oncol 1996;40:137-46.
21. Peters LJ, Ang KK, Thames HD. Accelerated fractionation in the radiation treatment of head and neck cancer: a critical comparison of different strategies. Acta Oncol 1988;27:185-94.
22. Saunders MI, Dische S, Barrett A, et al., on behalf of the CHART Steering Committee. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. Br J Cancer 1996;73:1455-62.
23. Cummings BJ, Keane TJ, Pintille M, et al. A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx [abstract]. Radiother Oncol 1996;40(Suppl 1):S30.
24. Lusinchi A, Lartigau E, Luboinski B, et al. Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. Int J Radiat Oncol Biol Phys 1994;29:149-52.
25. Bourhis J, Fortin A, Dupuis O, et al. Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. Int J Radiat Oncol Biol Phys 1995;32:747-52.
26. Munro AJ. An overview of randomised adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
27. Macmillan CH, Carrick K, Bradley PJ, et al. Concomitant chemo/radio-therapy for advanced carcinoma of the head and neck. Br J Radiol 1991;64:941-6.
28. Begg AC, Hoflard I, van Glabbeke M, et al. Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results for the EORTC cooperative trial 28851. Semin Radiat Oncol 1992;2:22-5.